inhalation technology

Clinical stage biopharmaceutical company, Pulmatrix, has received two key patents from the US Patent and Trademark Office for its inhaled drug delivery platform and its most advanced drug candidate for chronic obstructive pulmonary disease (COPD) Read more


An EU-funded project, Cupido, is researching the application of nanotechnologies in the cardiovascular field. Felicity Thomas explains more… Read more


Nemera is contributing to the EU-funded project Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts (Cupido), which is aimed at applying nanotechnologies to the cardiovascular field. Read more


US group Savara Pharmaceuticals has secured $10 million in financial backing to develop AeroVanc, the trade name of the first inhaled antibiotic designed to address the growing number of MRSA lung infections in cystic fibrosis patients. Read more

Medical product design and development company Team Consulting has demonstrated a new inhaler technology that could enable the future use of inhaled drugs for immunisation, pain relief, diabetes and many other conditions. The technology, once... Read more


Inhalation Sciences Sweden, a portfolio company of Karolinska Development, has received US Patent Approval for its flagship technology the PreciseInhale system. Read more


Ranking among the top five globally by production volume, the Indian pharmaceutical market today accounts for over 10% of global drug production. It continues to be one of India’s biggest employers, with more than 340,000 Indian employees... Read more